Cargando…

(18)F-FDG PET/CT Parameters for Predicting Prognosis in Esophageal Cancer Patients Treated With Concurrent Chemoradiotherapy

BACKGROUND AND AIMS: This study evaluated the prognostic value of (18)F-fluorodeoxyglucose positron emission tomography with integrated computed tomography ((18)F-FDG PET/CT) performed before and after concurrent chemoradiotherapy (CCRT) in esophageal cancer. METHODS: We analyzed the prognosis of 50...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Seokmo, Choi, Yunseon, Park, Geumju, Jo, Sunmi, Lee, Sun Seong, Park, Jisun, Shim, Hye-Kyung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264725/ https://www.ncbi.nlm.nih.gov/pubmed/34227434 http://dx.doi.org/10.1177/15330338211024655

Ejemplares similares

The role of interim FDG PET-CT after induction chemotherapy as a predictor of concurrent chemoradiotherapy efficacy and prognosis for head and neck cancer
por: Kim, Ka-Rham, et al.
Publicado: (2017)

(18)F-FDG PET-CT after Neoadjuvant Chemoradiotherapy in Esophageal Cancer Patients to Optimize Surgical Decision Making
por: Anderegg, Maarten C. J., et al.
Publicado: (2015)

Prognostic values of mid-radiotherapy (18)F-FDG PET/CT in patients with esophageal cancer
por: Kim, Nalee, et al.
Publicado: (2019)

Detecting Interval Distant Metastases With (18)F-FDG PET/CT After Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Cancer
por: Kroese, Tiuri E., et al.
Publicado: (2022)

PET/CT planning during chemoradiotherapy for esophageal cancer
por: Seol, Ki Ho, et al.
Publicado: (2014)

Prediction of outcome with FDG-PET in definitive chemoradiotherapy for esophageal cancer
por: Atsumi, Kazushige, et al.
Publicado: (2013)

(18)F-FDG-PET/CT-measured parameters as potential predictors of residual disease after neoadjuvant chemoradiotherapy in patients with esophageal carcinoma
por: Tustumi, Francisco, et al.
Publicado: (2022)

Value of (18)F-FDG PET/CT for Assessment of Advanced Lacrimal Sac Non-Keratinizing Squamous Cell Carcinoma Successfully Treated with Concurrent Chemoradiotherapy
por: Liao, Ching-Yu, et al.
Publicado: (2021)

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
por: Enomoto, Keisuke, et al.
Publicado: (2008)

Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
por: Enomoto, Keisuke, et al.
Publicado: (2009)

Diffusion-weighted MRI and (18)F-FDG PET/CT in assessing the response to neoadjuvant chemoradiotherapy in locally advanced esophageal squamous cell carcinoma
por: Xu, Xin, et al.
Publicado: (2021)

(18)F-FLT and (18)F-FDG PET/CT in Predicting Response to Chemoradiotherapy in Nasopharyngeal Carcinoma: Preliminary Results
por: Qi, Shi, et al.
Publicado: (2017)

Prognostic significance of preoperative (18)F-FDG PET/CT in uterine leiomyosarcoma
por: Park, Jeong-Yeol, et al.
Publicado: (2017)

Diagnosis of Graft Infection Using FDG PET-CT
por: Shim, Hunbo, et al.
Publicado: (2012)

The Role of (18) F-FDG PET/CT in Assessing Therapy Response in Cervix Cancer after Concurrent Chemoradiation Therapy
por: Choi, Jiyoun, et al.
Publicado: (2013)

Predictive Value of (18)F-FDG PET/CT Using Machine Learning for Pathological Response to Neoadjuvant Concurrent Chemoradiotherapy in Patients with Stage III Non-Small Cell Lung Cancer
por: Yoo, Jang, et al.
Publicado: (2022)

Pre-Chemoradiotherapy FDG PET/CT cannot Identify Residual Metabolically-Active Volumes within Individual Esophageal Tumors
por: Lu, W, et al.
Publicado: (2015)

Detection of primary sites in unknown primary tumors using FDG-PET or FDG-PET/CT
por: Park, Jong Sun, et al.
Publicado: (2011)

Diagnostic Accuracy of (18)F-FDG-PET/CT and (18)F-FDG-PET/MRI in Detecting Locoregional Recurrence of HNSCC 12 Weeks after the End of Chemoradiotherapy: Single-Center Experience with PET/MRI
por: Murtojärvi, Sarita, et al.
Publicado: (2022)

Candida Esophagitis Incidentally Detected by 18F-FDG PET/CT in Metastatic Lung Adenocarcinoma
por: Martínez-Amador, N, et al.
Publicado: (2017)

Gross Tumor Delineation in Esophageal Cancer on MRI Compared With (18)F-FDG-PET/CT
por: Vollenbrock, Sophie E., et al.
Publicado: (2019)

Volumetric Evaluation of Staging (18)F-FDG PET/CT Images in Patients with Esophageal Cancer
por: Karahan Şen, Nazlı Pınar, et al.
Publicado: (2022)

Value of (18)F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With (18)F-FDG PET/CT, MRI, and Contrast-Enhanced CT
por: Wang, Fei, et al.
Publicado: (2022)

Predictive value of metabolic 18FDG-PET response on outcomes in patients with locally advanced pancreatic carcinoma treated with definitive concurrent chemoradiotherapy
por: Topkan, Erkan, et al.
Publicado: (2011)

Prognostic Significance of Metabolic Parameters by (18)F-FDG PET/CT in Thymic Epithelial Tumors
por: Lee, Joohee, et al.
Publicado: (2021)

Muscular Sarcoidosis Detected by F-18 FDG PET/CT in a Hypercalcemic Patient
por: Han, Eun Ji, et al.
Publicado: (2013)

Combined pretreatment with (18)F-FDG PET/CT and Comet assay guides the concurrent chemoradiotherapy of locally advanced cervical cancer: study protocol for a randomized controlled trial
por: Ji, Shengjun, et al.
Publicado: (2018)

Prediction and diagnosis of interval metastasis after neoadjuvant chemoradiotherapy for oesophageal cancer using (18)F-FDG PET/CT
por: Goense, Lucas, et al.
Publicado: (2018)

(18)F-FDG PET versus (18)F-FDG PET/CT for Adrenal Gland Lesion Characterization: a Comparison of Diagnostic Efficacy in Lung Cancer Patients
por: Sung, Yon Mi, et al.
Publicado: (2008)

Metabolic Super Scan in (18)F-FDG PET/CT Imaging
por: Kim, Dae-Weung, et al.
Publicado: (2010)

The Prognostic Value of Sequential (18) F-FDG PET/CT Metabolic Parameters in Outcomes of Upper-Third Esophageal Squamous Cell Carcinoma Patients Treated with Definitive Chemoradiotherapy
por: Ha, Le Ngoc, et al.
Publicado: (2023)

Prognostic impact of (18)F-FDG PET/CT in pathologic stage II invasive ductal carcinoma of the breast: re-illuminating the value of PET/CT in intermediate-risk breast cancer
por: Park, Hye Lim, et al.
Publicado: (2023)

The usefulness of fluorodeoxyglucose-PET/CT for preoperative evaluation of ductal carcinoma in situ
por: Kim, Sungchul, et al.
Publicado: (2018)

Prognostic value of pretreatment (18)F-FDG PET-CT in radiotherapy for patients with hepatocellular carcinoma
por: Jo, In Young, et al.
Publicado: (2015)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

Scar Sarcoidosis on (18)F-FDG PET/CT
por: Arora, Saurabh, et al.
Publicado: (2019)

18F-FDG PET/CT and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

(18)F- FDG PET/CT-derived parameters predict clinical stage and prognosis of esophageal cancer
por: Mantziari, Styliani, et al.
Publicado: (2020)

Candida esophagitis incidentally detected by 18F‐FDG PET/CT in a patient with CNS lymphoma
por: Bayar, Melikşah, et al.
Publicado: (2021)

Identification of (18)F-FDG PET/CT Parameters Associated with Weight Loss in Patients with Esophageal Cancer
por: Galvez, Thierry, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_hv9gb980s8thrvh50sf66tkn37